33828546 21921367 35199314 27536672 10460937 23296949 26562836 19960305 23458172 11479148 12923723 21030574 10855940 12270983 24709471 31499475 18037104 12426730 10665939 19581908 11014374 10328506 10495797 9625665 25648906 11060727 25558821 12923722 - Search Results

Year	Number of Results
1997	4
1998	4
1999	6
2000	9
2001	5
2002	4
2003	5
2004	8
2005	2
2006	5
2007	7
2008	1
2009	7
2010	8
2011	5
2012	5
2013	12
2014	5
2015	11
2016	5
2017	6
2018	4
2019	5
2020	3
2021	4
2022	4

1

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy.

Tesar V, Hruskova Z. Tesar V, et al. Front Immunol. 2021 Mar 22;12:593288. doi: 10.3389/fimmu.2021.593288. eCollection 2021. Front Immunol. 2021. PMID: 33828546 Free PMC article. Review.

2

Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.

Matsumoto H, Nagaoka Y, Okada T, Wada T, Gondo A, Esaki S, Hayashi A, Miyaoka Y, Nakao T. Matsumoto H, et al. Intern Med. 2011;50(18):1905-10. doi: 10.2169/internalmedicine.50.5606. Epub 2011 Sep 15. Intern Med. 2011. PMID: 21921367 Free article.

3

Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.

Bose B, Chung EYM, Hong R, Strippoli GFM, Johnson DW, Yang WL, Badve SV, Palmer SC. Bose B, et al. J Nephrol. 2022 May;35(4):1159-1170. doi: 10.1007/s40620-022-01268-2. Epub 2022 Feb 23. J Nephrol. 2022. PMID: 35199314 Free PMC article.

4

Management of Membranous Nephropathy in Asia.

Xu J, Hu X, Xie J, Chen N. Xu J, et al. Kidney Dis (Basel). 2015 Sep;1(2):119-25. doi: 10.1159/000437288. Epub 2015 Sep 1. Kidney Dis (Basel). 2015. PMID: 27536672 Free PMC article. Review.

5

Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease.

Suki WN, Trimarchi H, Frommer JP. Suki WN, et al. Am J Nephrol. 1999;19(4):474-9. doi: 10.1159/000013501. Am J Nephrol. 1999. PMID: 10460937

6

Regaining tolerance to a self-antigen by the modified vaccination technique.

Barabas AZ, Cole CD, Lafreniere R, Weir DM. Barabas AZ, et al. Clin Rev Allergy Immunol. 2013 Oct;45(2):193-201. doi: 10.1007/s12016-012-8350-y. Clin Rev Allergy Immunol. 2013. PMID: 23296949 Review.

7

Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.

van de Logt AE, Beerenhout CH, Brink HS, van de Kerkhof JJ, Wetzels JF, Hofstra JM. van de Logt AE, et al. PLoS One. 2015 Nov 12;10(11):e0142033. doi: 10.1371/journal.pone.0142033. eCollection 2015. PLoS One. 2015. PMID: 26562836 Free PMC article. Clinical Trial.

8

Evidence-based practice guideline for the treatment of CKD.

Japanese Society of Nephrology. Japanese Society of Nephrology. Clin Exp Nephrol. 2009 Dec;13(6):537-66. doi: 10.1007/s10157-009-0237-8. Clin Exp Nephrol. 2009. PMID: 19960305 No abstract available.

9

Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population.

Zuo K, Wu Y, Li SJ, Xu F, Zeng CH, Liu ZH. Zuo K, et al. Clin Nephrol. 2013 Jun;79(6):445-53. doi: 10.5414/CN107681. Clin Nephrol. 2013. PMID: 23458172

10

Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.

Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G. Bazzi C, et al. Am J Kidney Dis. 2001 Aug;38(2):240-8. doi: 10.1053/ajkd.2001.26080. Am J Kidney Dis. 2001. PMID: 11479148 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results